期刊文献+

鼻腔鼻窦癌远处转移的危险因素分析 被引量:3

Associated risk factors for distant metastasis in sinonasal carcinoma
下载PDF
导出
摘要 目的探讨与鼻腔鼻窦癌远处转移显著相关的危险因素。方法回顾性分析2003年1月-2013年1月该院耳鼻喉科收治的76例鼻腔鼻窦癌患者的临床病理资料,单因素和多因素回归分析鼻腔鼻窦癌远处转移与临床病理因素的关系。结果鼻腔鼻窦癌远处转移的发生率为15.79%(12/76),其中肺转移占7.89%(6/76),颅内转移占3.95%(3/76),骨转移占2.63%(2/76),肝转移1.31%(1/76)。2例初诊入院时即发现远处转移,其余患者从初诊入院治疗到发现远处转移的时间间隔为4~51个月,间隔中位时间为11个月。鼻腔鼻窦癌远处转移患者的3年和5年累计生存率分别为33.3%和16.7%。对76例鼻腔鼻窦癌进行单因素分析显示病理分化程度(P=0.042)、T分期(P=0.032)以及N分期(P=0.001)均与鼻腔鼻窦癌远处转移有关;多因素回归分析显示N分期与鼻腔鼻窦癌的远处转移显著相关(P=0.042)。结论鼻腔鼻窦癌存在一定比率的远处转移,主要发生在肺转移,其中N分期是影响鼻腔鼻窦癌远处转移的独立危险因素。 Objective To investigate risk factors for distant metastasis in sinonasal carcinoma. Methods Clinicopathological data of 76 patients with sinonasal carcinoma treated at our hospital from January 2003 to January 2013 were retrospectively analyzed. The associa tions between distant metastasis and clinicopathological factors were evaluated by univariate analysis and multivariable logistic regression analysis. Results The overall incidence of distant metastasis in sinonasal carcinoma was 15.79% (12/76). The target site of distant me tastasis was mainly in lung 7.89% (6/76), brain 3.95 % ( 3/76), bone 2.63 % ( 2/76 ), liver 1.31% ( 1/76 ). Patients were diagnosed distant metastasis when admitted, and the rest with time interval between 4 and 51 months ( median 11 months ). The 3-year and 5-year cumulative survivals in sinonasal carcinoma with distant metastasis were 33.3% and 16.7% respectively. Univariate analysis showed that tumor differentiation ( P = 0.042), T stage ( P = 0. 032), N stage ( P = 0. 001 )were associated with distant metastasis. Muhivariable logistic regression analysis showed N stage remained as significant risk factors (P = 0.042). Conclusions Sinonasal carcinoma has certain per centage of distant metastasis,which is mainly in lung and their prognosis is usually poor. N stage is risk factor for lymph node metastasis in sinonasal carcinoma.
作者 朱俊所
出处 《安徽医药》 CAS 2013年第10期1748-1749,共2页 Anhui Medical and Pharmaceutical Journal
关键词 鼻腔鼻窦癌 远处转移 危险因素 sinonasal carcinoma distant metastasis risk factors
  • 相关文献

参考文献1

二级参考文献14

  • 1DUI.GUEROV P, JACOBSEN M S, ALI.AL A S, et al. Nasal and paranasal sinus carcinoma: are we mak- ing progress? A series of 220 patients and a systemat- ic review[J]. Cancer, 2001,92: 3012-3029.
  • 2MENDENHAI.I. W M, AMDUR R J, MORRIS C G, et al. Carcinoma of the nasal cavity and paranasal sinuses[J]. I.aryngoscope,2009,119:899-906.
  • 3RINALDO A, FERLITO A, SHAHA A R,et al. Is elective neck treatment indicated in patients with squamous cell carcinoma of the maxillary sinus[J]? Acta Otolaryngol, 2002,122 .. 443 - 447.
  • 4TIWARI R, HARDILLO J A, MEHTA D, et al. Squamous cell carcinoma of maxillary sinus[-J]. Head Neck, 2000,22 : 164- 169.
  • 5MCKAY S P, SHIBUYA T Y, ARMSTRONG W B, et al. Cell carcinoma of the paranasal sinuses and skull base[J]. Am J Otolaryngol, 2007,28 : 294-301.
  • 6LAWSON W, PATEL Z M. The evolution of man- agement for inverted papilloma: an analysis of 200 ca- ses[J]. Otolaryngol Head Neck Surg, 2009, 140: 330-335.
  • 7郑中立.耳鼻喉科诊断学[M].2版.北京:人民卫生出版社,2006:530-530.
  • 8STREK P, ZAGOLSKI O, SKLADZIEt;I J,et al. Os-teomas of the paranasal sinuses; surgical treatment options[J]. Med Sci Monit, 2007,13 : CR244-250.
  • 9CHUGH R, TAWBI H, LUCAS D R,et al. Chordo- ma: the nonsarcoma primary bone tumour[J]. Oncolo- gist, 2007,12 : 1344 - 1350.
  • 10CHIM C S, MA S Y, AU W Y, et al. Primary nasal natural killer cell lymphoma:long-term treatment out- come and relationship with the international Prognos- tic Index[J]. Blood, 2004,103 : 216 - 221.

共引文献22

同被引文献30

  • 1ZHANG Y,WEI M.Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma:a meta-analysis[J].Tumour Biol,2014,35:1745-1749.
  • 2MAYINUER A,YASEN M,MOGUSHI K,et al.Upregulation of protein tyrosine phosphatase type IVA member 3(PTP4A3/PRL-3)is associated with tumor differentiation and a poor prognosis in human hepatocellular caicinoma[J].Ann Surg Oncol,2013,20:305-317.
  • 3FIORDALISI J J,KELLER P J.COX A D.PRL tyrosine phosphatases regulate Rho family GTPases to promote invasion and motility[J].Cancer Res,2006,66:3153-3161.
  • 4BILICI A,USTAALIOGLU B B,YAVUZE R,et al.Prognosis significance of high phosphatase of regenerating liver-3expression in patients with gastric cancer who underwent curative gastrectomy[J].Dig Dis Sci,2012,57:1568-1575.
  • 5PENG L,XING X,LI W,et al.PRL-3promotes the motility,invasion,and metastasis of LoVo colon cancer cellas through PRL-3-integrin betal-ERK1/2 andMMP2signaling[J].Mol Cancer,2009,8:110-116.
  • 6HSU A W,SODHI A,EBERHART C,et al.Regression of choroidal neovasularization in response to systemie chemotherapy for cancer[J].Canadian J Ophthalmol,2013,48:e80-e82.
  • 7NIEVES B J,D'AMORE P A,BRYAN B A,et al.The function of vascular endothelial growth factor[J].Biofactors,2009,35:332-337.
  • 8DAS M,WAKELEE H.Targeting VEGF in hung cancer[J].Expert Opin Ther Target,2012,16:395-406.
  • 9MING J,LIU N,GU Y.PRL-3facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer[J].Pathology,2009,41:118-126.
  • 10Azarpira N, Ashraf MJ, Khademi B, et al. Khademi, distant metastases to nasal cavities and paranasal sinuses case series[J].Indian J Otolaryngol Head Neck Surg.2011, 63(4):349-352.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部